secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K/A
Filed at:   2026-09-17T20:10:38+00:00
Accession:  0001493152-26-043120
Event type: m_and_a
Sentiment:  negative
Materiality: 0.80
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nomad Power closes reverse merger with NOMAD; target flags going-concern doubt, $8.4M 2025 loss
--------------------------------------------------------------------------------

- Merger closed July 1, 2026; NOMAD survives as wholly-owned subsidiary; Lixte renamed Nomad Power Solutions (NMAD).
- NOMAD 2025 revenue $9.35M (product sales $9.15M), up ~299% from $2.35M in 2024; net loss $8.4M.
- Auditors cite substantial doubt about going concern: $156K cash, $11.7M stockholders' deficit at 12/31/2025.
- June 16, 2026: $6.5M 15% secured note repaid bank loan; note applied to working capital; $9.0M remaining commitment funded at close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226043120/0001493152-26-043120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226043120/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-043120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer